Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Weijia fang"
8
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT04652219
Completed
Early Phase 1
CART Therapy in GUCY2C-positive Digestive Tract Tumors
Innovative Cellular Therapeutics Co., Ltd.
ClinicalTrials.gov
NCT04652219
Completed
Early Phase 1
CART Therapy in GUCY2C-positive Digestive Tract Tumors
Innovative Cellular Thera...
NCT05372692
Completed
Not Applicable
Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer
Nanjing Blue Shield Biotech Co.,Ltd
ClinicalTrials.gov
NCT05372692
Completed
Not Applicable
Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovar...
Nanjing Blue Shield Biote...
NCT05396300
Completed
Phase 1
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors
Chongqing Precision Biotech Co., Ltd
ClinicalTrials.gov
NCT05396300
Completed
Phase 1
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced...
Chongqing Precision Biote...
NCT05518253
Recruiting
Phase 1
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Chongqing Precision Biotech Co., Ltd
ClinicalTrials.gov
NCT05518253
Recruiting
Phase 1
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanc...
Chongqing Precision Biote...
NCT05862168
Recruiting
Phase 2
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial
Weijia Fang, MD
ClinicalTrials.gov
NCT05862168
Recruiting
Phase 2
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced...
Weijia Fang, MD
NCT05947201
Unknown
Phase 2
Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Akeso Pharmaceuticals, Inc.
ClinicalTrials.gov
NCT05947201
Unknown
Phase 2
Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and...
Akeso Pharmaceuticals, In...
NCT06821048
Recruiting
Phase 1
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
Chongqing Precision Biotech Co., Ltd
ClinicalTrials.gov
NCT06821048
Recruiting
Phase 1
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced M...
Chongqing Precision Biote...
NCT07420010
Not Yet Recruiting
Early Phase 1
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Weijia Fang, MD
ClinicalTrials.gov
NCT07420010
Not Yet Recruiting
Early Phase 1
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, P...
Weijia Fang, MD
Result Breakdown
Status
Completed
3 (38%)
Recruiting
3 (38%)
Unknown
1 (13%)
Not yet recruiting
1 (13%)
Phase
Phase 1
3 (38%)
Early Phase 1
2 (25%)
Phase 2
2 (25%)
not_applicable
1 (13%)
Top Conditions
Ovarian Cancer
3 (38%)
Colorectal Cancer
2 (25%)
Malignant Neoplasms of Digestive Organs
1 (13%)
Show 7 more
Top Sponsors
Weijia Fang, MD
8 (100%)
Chongqing Precision Biotech Co., Ltd
3 (38%)
Innovative Cellular Therapeutics Co., Ltd.
1 (13%)
Show 2 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease